Fig. 2From: Assessing antiviral treatment efficacy and risk factors for severe COVID-19 in kidney transplant recipients during the Omicron subvariant-dominant period: a retrospective studyComparison of clinical parameters between groups with mild/moderate and severe/critical COVID-19 Box plot of clinical parameters between groups. (A) Age, (B) Time from symptom onset to initial antiviral therapy, (C) BMI, (D) Dose of previous vaccination, (E) eGFR.Back to article page